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Abstract: Purpose: Dry eye syndrome (DES) is a common disease with an increasing occurrence.
Although DES symptoms are considered mild, it can reduce quality of life for individuals. Many
studies on DES have been conducted, but these focused on the use of electronic devices. Here, we
investigate an association between DES and sleep disorders in the context of emerging health issues.
Methods: Our data came from the National Health Insurance Service (NHIS) National Sample Cohort,
which included 44,366 patients and was based on a 1:1 matching method (sleep disorder patients vs.
patients without sleep disorders) during 2012–2015. Using survival analysis with a Cox proportional
hazard model, we identified an association of sleep disorders with DES. Results: About 16.7% of
all patients were diagnosed with DES, and prevalence was higher in patients with sleep disorders
(sleep disorders: 19.82%, no sleep disorders: 13.67%). Survival analysis showed that sleep disorders
positively correlated with DES diagnosis (Hazard Ratio (HR): 1.320, 95% Confidence Interval (CI):
1.261–1.382, p-value < 0.0001). Positive trends were enhanced in males, younger patients, lower
economic levels, and with higher severity of comorbid. Conclusions: Our findings suggest that sleep
disorder was positively associated with DES. This correlation can be helpful in effective management
of both sleep disorders and DES in South Koreans.
Keywords: sleep disorders; dry eye syndromes; quality of life; eye diseases
1. Introduction
South Korea has experienced many developments and changes in the last century, including
new social and economic phenomena [1,2]. Overall socioeconomic levels and health status of South
Koreans rapidly improved. However, with such rapid change, people face challenges, and most of
them experience psychiatric problems caused by increasing stressful events [3]. Psychiatric problems
can include mild stress as well as suicidal behavior, and sleep disorder is considered to be an important
related factor. This is because sleep is substantial part of daily life, and deficit or excess of sleep can
cause additional problems [4]. In addition, people without psychiatric problems could be faced with
that [5,6].
According to the National Health Insurance Service (NHIS) in South Korea, the number of patients
with organic sleep disorders is rapidly increasing each year (2010: 287,835 to 2016: 494,915) [7]. To
solve this problem, patient and healthcare professional’s attentions have shifted to the importance of
managing quality of sleep and problems related to sleep. Thus, previous studies have suggested that
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many problematic physical or psychiatric conditions were caused by sleep disorders, even if patients
had no accompanying psychiatric problems [8–10]. Sleep quality and sleep duration are now known
to be essential factors in managing health. Although many health problems are associated with sleep
disorders, in this study, we focus on dry eye syndrome (DES).
DES is one of the most common eye diseases and according to NHIS reports, the number of cases
is continuously increasing (2007: 1,426,549 to 2016: 2,244,627) [11]. Many studies have been conducted
regarding this increase, and most healthcare professionals have suggested that increased electronic
device usage, including smart phones, causes DES [12,13]. Although DES symptoms are considered
mild, some psychiatric studies suggest that DES reduces the quality of an individual’s daily life due to
uncomfortable stress [14]. In severe cases, DES can contribute to other physical symptoms, such as
worsening vision. In addition, medical costs attributed to DES ($85.8 million in 2016, 10% increase per
year) indicate that development of alternatives for effective management of DES is needed [11].
Even though some cross-sectional/case-control studies based on patient clinics have shown
positive association between DES and sleep disorders [15–17], there are few large-scale or nationwide
studies. In particular, no findings associate DES with sleep disorders using national claim data in South
Korea, because DES (International Classification of Diseases [ICD]-10 code: H04.11; new classification
in 2011) was not identified in healthcare claim data before 2011. Thus, in this study, we investigate the
association between the organic sleep disorders and DES using national claim data in South Korea.
Based on our results, we suggest helpful evidence for establishing alternatives or health policy to
prevent new healthcare problems due to emerging health issues.
2. Methods
2.1. Study Population
The data used in this study was the NHIS National Sample Cohort 2002–2015, which was released
by the NHIS in 2017 (research No. NHIS-2017-2-568). These data include 1,000,000 representative
individuals who were randomly selected from the South Korean population in 2006. The data include
all medical claims filed from January 2002 to December 2015. In consideration of the 2011 classification
of DES in South Korean healthcare claim data, we first excluded all patients who were deceased, and
then identified patients who were diagnosed with DES (ICD-10: H04.11) or sleep disorders (ICD-10:
G47) before 2012, and assumed that these patients were newly diagnosed with DES or sleep disorders.
We excluded patients who were diagnosed with DES before sleep disorders. Finally, we identified
22,183 patients with sleep disorders during 2012–2015. To design the matched cohort study using
the sleep disorder patients as the case group, we established the control group by propensity score
matching by adjusting for same sex, similar age (5-year intervals), and similar date of diagnosis for
sleep disorders. We used a 1:1 matching method to select the control group (22,183 patients) who
were not diagnosed with sleep disorders. Finally, the data used in this study contained the records of
44,366 patients from 2012 to 2015. This study was approved by an Institutional Review Board and the
National Health Insurance Service Ilsan Hospital (NHIMC 2017-09-015).
2.2. Variables
The outcome variable in this study was whether patients were diagnosed with DES, according to
the presence of sleep disorders. We identified the date of each patient’s first hospital visit with DES as
the main diagnosis (either outpatient care or inpatient care, ICD-10 code H04.11) from 2012 to 2015
and categorized that patient into the DES diagnosis group.
The major variable of interest was the diagnosis of sleep disorders. In this study, sleep disorders
were defined as organic sleep disorders (ICD-10: G47.x), not included non-organic sleep disorders
(F41.x). Organic sleep disorder consists of insomnia, hypersomnia, disorders of the sleep-wake
schedule, sleep apnea, narcolepsy/cataplexy, and other sleep disorders.
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To investigate the association between DES and sleep disorders in this study, we included the
following independent variables: sex, age, economic level, type of insurance coverage, Charlson
comorbidity index (CCI), and region. Age was classified by 10 year intervals: less than 29 years,
30–39 years, 40–49 years, 50–59 years, 60–69 years, 70–79 years, and more than 80 years. Economic
level was defined by insurance premiums in claim data. In South Korea, all people apply to the
NHI and pay insurance premiums based on their economic level, determined by salary or property
(generally about 7% of salary was paid as premium in 2017; this proportion changes every year). Thus,
insurance premiums can indirectly reflect economic level. We classified economic level as: less than
30% (low income), 31–60%, 61–90%, and more than 91% (high income). Insurance coverage is divided
into three types in South Korea. If patients are workers, employers in workplaces, public officials,
private school employees, continuously insured persons, or daily paid workers at construction sites,
they are defined as an NHI employee. Those with NHI employee insurance pay a regular portion
of their average salary in contribution payments, and include spouses, dependents, siblings, and
parents. The NHI self-employed insurance category includes people who do not fall into the NHI
employee insurance group. Their contribution amount is set by taking into account their income,
property, living standard, and rate of participation in economic activities. Medical aid beneficiaries
are defined as patients with an income below the government-defined poverty level, or as those with
a disability who were provided with free inpatient and outpatient care paid by government funds.
Therefore, the type of insurance coverage represents each patient’s socioeconomic status. The CCI
was calculated by weighing and scoring for comorbid conditions, with additional points added to
account for comorbidities that may affect health outcomes of patients [18]. CCI was categorized into
three groups: ‘0’, ‘1’, ‘2’, and ‘more than 3’.
2.3. Statistical Analysis
To investigate the association between DES and sleep disorders, we first examined the frequencies
and percentages of the study population by DES diagnosis. Next, we performed a log-rank test
and generated a Kaplan-Meier survival curve using product-limit method to compare the rates of
diagnosis for DES between patients with or without sleep disorders. Finally, we performed survival
analysis using the Cox proportional hazard model to identify the association of sleep disorder with
DES, adjusting for independent variables. In addition, to examine the differences in the association
between DES and sleep disorder, we performed sub-group analysis for survival analysis according
to sex, age, economic level, and CCI. All statistical analyses were performed using SAS statistical
software version 9.2 (SAS Inc., Cary, NC, USA).
3. Results
We analyzed 44,366 patients diagnosed with sleep disorders or not during 2012–2015, using a
1:1 propensity score matching method (sleep disorder patients vs. patients without sleep disorders).
Table 1 shows the distribution of study population by each variable. About 16.7% of total patients were
diagnosed with DES, and its prevalence was higher in patients with sleep disorders (sleep disorders:
19.82%, no sleep disorders: 13.67%). By sex, female patients had more frequent DES diagnosis than
males. Older patients were more often diagnosed with DES than younger patients, and patients with
higher economic levels were more diagnosed with DES than low income groups. These trends were
also observed when results were analyzed by the types of insurance coverage: NHI employee insured
patients were more diagnosed with DES than Medical Aid patients. As an indication of health severity
for each patient, the CCI had inverse trends with DES diagnosis. In addition, patients who lived in
metropolitan areas visited medical institutions due to DES more often than rural patients.
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Table 1. General characteristics of the study population.
Variables
Total
Dry Eye Syndrome
Diagnosed None
N % N % N %
Sleep disorder
Yes 22,183 50.00 4397 19.82 17,786 80.18
No 22,183 50.00 3032 13.67 19,151 86.33
Sex
Male 19,893 44.84 2564 12.89 17,329 87.11
Female 24,473 55.16 4865 19.88 19,608 80.12
Age (Years)
<29 1312 2.96 125 9.53 1187 90.47
30–39 3498 7.88 515 14.72 2983 85.28
40–49 5694 12.83 736 12.93 4958 87.07
50–59 7804 17.59 1145 14.67 6659 85.33
60–69 10,385 23.41 1902 18.31 8483 81.69
70–79 7227 16.29 1466 20.29 5761 79.71
>80 8446 19.04 1540 18.23 6906 81.77
Economic level
<30% (low) 12,195 27.49 2007 16.46 10,188 83.54
31–60% 10,805 24.35 1659 15.35 9146 84.65
61–90% 14,577 32.86 2504 17.18 12,073 82.82
>91% (high) 6789 15.30 1259 18.54 5530 81.46
Types of insurance coverage
Medical aid 1984 4.47 307 15.47 1677 84.53
NHI, self–employed insured 14,581 32.87 2362 16.20 12,219 83.80
NHI, employee insured 27,801 62.66 4760 17.12 23,041 82.88
Charlson comorbidity index
0 37,081 83.58 6226 16.79 30,855 83.21
1 4682 10.55 802 17.13 3880 82.87
2 1771 3.99 280 15.81 1491 84.19
3+ 832 1.88 121 14.54 711 85.46
Region
Metropolitan 20,021 45.13 3496 17.46 16,525 82.54
Others 24,345 54.87 3933 16.16 20,412 83.84
Total 44,366 100.00 7429 16.74 36,937 83.26
NHI: National Health Insurance.
Figure 1 shows the Kaplan-Meier survival curve generated using product-limit methods to
compare the incidence of DES during the study period between patients with sleep disorders and
without sleep disorders. In the survival curve, patients with sleep disorders were more often diagnosed
with DES than patients without sleep disorders (p-value for log-rank test < 0.0001).
Table 2 shows the results of survival analysis using the Cox proportional hazard model to identify
an association between DES and sleep disorder while adjusting for other independent variables. Sleep
disorder positively correlated with DES diagnosis (HR: 1.320, 95% CI: 1.261–1.382, p-value < 0.0001).
Of the independent variables, female and older patients were more associated with DES than other
variables. The top 10% of economic levels and patients insured as NHI employees were more often
diagnosed with DES than lower socioeconomic levels. In contrast, the results comparing CCI with
DES were not statistically significant. Regional variables were also associated with DES (Metropolitan
= HR: 1.080, 95% CI: 1.039–1.122, p-value < 0.0001).
Int. J. Environ. Res. Public Health 2019, 16, 878 5 of 10
Int. J. Environ. Res. Public Health 2019, 16, x  5  of  10 
 
 
Figure 1. Kaplan‐Meier survival curve for incidence of dry eye syndrome (DES). The results of log‐
rank test for time to DES by diagnosis of sleep disorders were statistically significant. 
Figure  1  shows  the Kaplan‐Meier  survival  curve  generated  using  product‐limit methods  to 
compare the incidence of DES during the study period between patients with sleep disorders and 
without  sleep  disorders.  In  the  survival  curve,  patients  with  sleep  disorders  were  more  often 
diagnosed with DES than patients without sleep disorders (p‐value for log‐rank test < 0.0001). 
Table  2  shows  the  results  of  survival  analysis using  the Cox proportional hazard model  to 
identify  an  association  between DES  and  sleep  disorder while  adjusting  for  other  independent 
variables. Sleep disorder positively correlated with DES diagnosis (HR: 1.320, 95% CI: 1.261–1.382, p‐
value < 0.0001). Of the independent variables, female and older patients were more associated with 
DES than other variables. The top 10% of economic levels and patients insured as NHI employees 
were  more  often  diagnosed  with  DES  than  lower  socioeconomic  levels.  In  contrast,  the  results 
comparing CCI with DES were not statistically significant. Regional variables were also associated 
with DES (Metropolitan = HR: 1.080, 95% CI: 1.039–1.122, p‐value < 0.0001). 
Table 2. Results of survival analysis using Cox proportional hazard model for association between 
sleep disorders and dry eye syndrome. 
Variables 
Dry Eye Syndrome 
HR  95% CI  p–Value 
Lower  Upper 
Sleep disorder         
Yes  1.320  1.261  1.382  <0.0001 
No  1.000  –  –  – 
Sex         
Male  0.640  0.615  0.667  <0.0001 
Female  1.000  –  –  – 
Age (Years)         
<29  1.000  –  –  – 
30–39  1.594  1.350  1.882  <0.0001 
40–49  1.473  1.255  1.729  <0.0001 
50–59  1.688  1.445  1.973  <0.0001 
60–69  2.123  1.822  2.475  <0.0001 
70–79  2.479  2.124  2.894  <0.0001 
i re 1. Kaplan-Meier survival curve for incidence of dry e e syndrome (DES). The results of log-rank
test for time to DES by diagnosis of leep disorders were statistic lly significa t.
Table 2. Results of survival analysis using Cox proportional hazard model for association between
sleep disorders and dry eye syndrome.
Variables
Dry Eye Syndrome
HR
95% CI
p-Value
Lower Upper
Sleep disorder
Yes 1.320 1.261 1.382 <0.0001
No 1.000 – – –
Sex
Male 0.640 0.615 0.667 <0.0001
Female 1.000 – – –
Age (Years)
<29 1.000 – – –
30–39 1.594 1.350 1.882 <0.0001
40–49 1.473 1.255 1.729 <0.0001
50–59 1.688 1.445 1.973 <0.0001
60–69 2.123 1.822 2.475 <0.0001
70–79 2.479 2.124 2.894 <0.0001
>80 2.225 1.906 2.597 <0.0001
Economic lev l
<30% (low) 1.000 – – –
31–60% 0.960 0.907 1.016 0.1622
61–90% 1.029 0.977 1.084 0.2844
>91% (high) 1.086 1.020 1.155 0.0094
Types of insurance coverage
Medical aid 0.949 0.858 1.049 0.3056
NHI, self–employed insured 0.940 0.902 0.980 0.0037
NHI, employee insured 1.000 – – –
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Table 2. Cont.
Variables
Dry Eye Syndrome
HR
95% CI
p-Value
Lower Upper
Charlson comorbidity index
0 1.000 – – –
1 1.053 0.991 1.119 0.0931
2 1.019 0.928 1.119 0.6983
3+ 1.012 0.882 1.161 0.8621
Region
Metropolitan 1.080 1.039 1.122 <0.0001
Others 1.000 – – –
Figure 2 shows the results of sub-group analysis for survival analysis. When organizing the
results by sex, sleep disorder was more associated with DES in male patients (male, sleep disorders
= HR: 1.326, 95% CI: 1.227–1.434, p-value < 0.0001; female, sleep disorders = HR: 1.315, 95% CI:
1.243–1.391, p-value < 0.0001). Positive trends were increased in younger patients than in older patients.
In addition, patients at low economic levels had more positive correlation between DES and sleep
disorders than higher income groups. On the other hand, the increased trends by sleep disorders were
higher in patients with a higher CCI value than in patients with a low CCI (0/1, sleep disorders = HR:
1.319, 95% CI: 1.258–1.383, p-value < 0.0001; 2/3+, sleep disorders = HR: 1.364, 95% CI: 1.148–1.622,
p-value = 0.0004).
Int. J. Environ. Res. Public Health 2019, 16, x  6  of  10 
 
>80  2.225  1.906  2.597  <0.0001 
Economic level         
<30% (low)  1.000  –  –  – 
31–60%  0.960  0.907  1.016  0.1622 
61–90%  1.029  0.977  1.084  0.2844 
>91% (high)  1.086  1.020  1.155  0.0094 
Types of insurance coverage         
Medical aid  0.949  0.858  1.049  0.3056 
NHI, self–employed insured  0.940  0.902  0.980  0.0037 
NHI, employee insured  1.000  –  –  – 
Charlson comorbidity index         
0  1.000  –  –  – 
1  1.053  0.991  1.119  0.0931 
2  1.019  0.928  1. 19  0.6983 
3+  1.012  0.882  1.161  0.8621 
Regi n         
Metropolitan  1.080  1.039  1.122  <0.0001 
Others  1.000  –  –  – 
i re      t   lt   f  ‐   l i   f   i l  l i .  e   r i i   t  
r s lts    ,  l   i r r      i t   it    i   l   ti t  ( l ,  l   i r rs 
 HR: 1.326, 95% CI: 1.227–1.43 , p‐value < 0.00 1; female, sleep disor ers = HR: 1.315, 95% CI: 1.243–
.391, p‐value < 0.0001). Positive trends were inc ased in younger patients than in older patients. In 
addition, patients  at  low  econ mic  lev ls  had more positive  correlation  betwe n DES  and  sl e  
i   t  higher  income groups. On  the other hand,  the  incr ased  trends by sleep  isord rs 
were higher in patients with a higher CCI value than in patients with a low CCI (0/1, sleep disorders 
= HR: 1.319, 95% CI:  .258–1.383, p‐value < 0.0001; 2/3+, sleep  isorders = HR: 1.364, 95% CI: 1.148–
1.622, p‐value = 0.0004). 
 
Figure 2. The results of sub‐group analysis for survival analysis according to sex, age, economic level, 
and CCI. The HR as marked by the square points was calculated by survival analysis to investigate 
the association between sleep disorder and DES. Results were considered statistically significant  if 
each bar marked to SD did not reach the cut‐off line of 1.000. 
i r 2. The results of sub-group analysis for survival analysis according to sex, age, economic level,
a I. s arked by the square points was calculated by survival n lysis to investigate the
association betw en sleep disorder and DES. Results were considere statistically significant if each
bar m ked to SD did not reach the cut-off line of 1.000.
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4. Discussion
Considering emerging trends in healthcare, there is a continuous need for alternative strategies
for effective management. For most health issues, problems include a lack of optimal alternatives. In
some parts of the South Korean healthcare arena and due to a challenging social atmosphere, there
are still uncontrollable healthcare issues that contribute to psychiatric problems, including stress and
suicide. Sleep is one such health problem. In recent times, most South Koreans have had hectic days
and naturally, the duration of sleep was less than other countries [19]. Thus, many studies investigate
the deficits in sleep quality and duration in South Korea, and the major focus of these findings has been
on severe symptoms, such as cancer, cardiovascular disease, and psychiatric symptoms. However,
although DES cases have continuously increased each year, there are few studies about risk factors for
DES or its association with sleep disorders. Therefore, we investigated the association between these
conditions, considering that cases of both diseases are increasing.
Our findings suggest that the sleep disorders, which were not caused by psychiatric problems,
was positively associated with increasing DES in South Korea. In results of previous studies, the
association between sleep disorders and DES was analyzed; in particular, shorter sleep duration was a
major contributor to DES [16,20,21]. In addition, some professionals suggest that the DES could be
caused by reducing quality of sleep, such as by sleep disturbance [17]. A recent study also showed
that sleep disorders were prevalent in DES, and sleep quality was affected by symptom severity in
DES patients [22]. However, due to the lack of data to study such an association because of the new
classification of DES in claim data, there are no clear findings associating DES and sleep disorders
in South Korea, except in the context of lacrimal system disorder (ICD-10: H04) or a cross-sectional
study [23]. In a randomized clinical trial study, it was suggested that sleep deprivation reduces tear
secretion and could trigger ocular surface diseases [24]. However, DES has an unknown etiology and a
mechanism to support the association of sleep disorders with DES is still unclear [25]. As included
various sleep disorders such as hypersomnia and disturbed sleep time as well as insomnia, our results
could not provide an evidence supporting mechanisms relating to sleep deprivation. Our findings
about the emerging diseases of sleep disorder and DES may inform decisions made by healthcare
professionals. Future researches are warranted to logically support these associations.
Our study also has some interesting findings based on sub-group analysis. Generally, people with
more accessibility or attention for healthcare, such as high income or metropolitan residents, was more
diagnosed with DES. However, the positive correlation between DES and sleep disorders was greater
in male, younger, and poorer groups. This was because these associations were more likely to affect
DES risk in populations with lower initial risk. In other words, in populations with low risk for DES,
sleep disorder could be a major risk factor. In developing effective approaches, these findings provide
information for managing DES. On the other hand, patients with more health severity as determined
by CCI had a more positive correlation between DES and sleep disorder. This observation might be
explained by the clinical vulnerability of this population. Thus, in severe health patients, managing
sleep conditions could be a key factor in preventing DES.
Our study has several strengths related to the study population and methodology. First, to our
best knowledges, this study is the first attempt to investigate an association between sleep disorder
without psychiatric problems and DES in South Korea. As previously mentioned, DES was clear
classified as distinct from lacrimal system disorder after 2011, and the cohort data which included this
information was only recently disclosed. Thus, there are few studies about factors associated with DES
in South Korea. Therefore, this study is helpful in informing clinical decisions or evidence-based health
policy for managing new emerging diseases. Second, the South Korean government has introduced
the NHI for the overall population and collects healthcare claims information related to the payment
system. The data used in this study was from a retrospective cohort study, which included healthcare
claim data from more than 10 years of the NHI system. Thus, the results generated from this data
provide more detailed analysis than other type of data. Third, in this study, we used a matched cohort
design, using propensity score matching (1:1). Therefore, our findings minimize selection bias and
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recall bias [26]. Finally, previous studies showed that pre-existing clinical conditions could adversely
affect patient outcomes. Therefore, we adjusted for previous psychiatric hospitalization and CCI in
this study.
Our study also has some limitations. First, because we use insurance claim data, we depend
on the ICD-10 code to define the diagnoses of sleep disorder and DES. Therefore, there could be an
under- or overestimation of diagnosis in the study population. Nevertheless, the data included the
overall population in South Korea and is only limited based on using claim data. Second, the severity
of sleep disorder could be influenced by using pharmaceuticals. However, psychotic drugs for sleep
disorder (G47), such as Benzodiazepines, are not covered by NHI [27]. Thus, we could not measure
medicine as a severity factors for sleep disorder due to the nature of the claim data. Furthermore, we
could not evaluate the effect of the drug treatment of sleep disorders on DES. Third, previous studies
identified other factors that could affect the patient’s condition, such as use of electronic devices,
job status, and social relationship. However, we could not consider such factors in this study due
to the limitations of the healthcare claim data. Fourth, our claim data was not available to classify
DES based on the subtypes such as evaporative or secretive type. It would be interesting to evaluate
what kind of DES better correlates with sleep disorders in the future. Fifth, the positive association
between sleep disorders and DES may be linked to the socioeconomic status of South Korea. Thus,
it is unreasonable to generalize our findings to other countries with different socioeconomic and
demographic characteristics.
Although there are some limitations related to the methods of this study, our findings suggest that
sleep disorders could be associated with incidence of DES, and that this association was greater
in patients with less access to medical resources and with higher severity of comorbid clinical
conditions. Our findings suggest that there needs to be more effective alternatives for managing
emerging diseases, such as sleep disorder or DES. A solution for these issues will improve the quality
of life for South Koreans.
5. Conclusions
Our findings suggest that sleep disorders could cause DES. This relationship can be helpful in
effective management of both sleep disorders and DES in South Koreans. In addition, strategies need
to be developed for managing emerging health problems, including sleep disorders or DES.
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